The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria
Open accessAbstract
Diseases caused by antibiotic-resistant bacteria in hospitals are the outcome of complex relationships between several dynamic factors, including bacterial pathogenicity, the fitness costs of resistance in the human host, and selective forces resulting from interventions such as antibiotic therapy. The emergence and fate of mutations that drive antibiotic resistance are governed by these interactions. In this review, we will examine how different forms of antibiotic resistance modulate bacterial fitness and virulence potential, thus influencing the ability of pathogens to evolve in the context of nosocomial infections. We will focus on 3 important multidrug-resistant pathogens that are notoriously problematic in hospitals: Pseudomonas aeruginosa, Acinetobacter baumannii, and Staphylococcus aureus. An understanding of how antibiotic resistance mutations shape the pathobiology of multidrug-resistant infections has the potential to drive novel strategies that can control the development and spread of drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iron in infection and immunity
Cassat, J. E., & Skaar, E. P. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.04.010 · Cited by 1,214
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus
Otto, M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134309 · Cited by 457
Hammer, N. D., Cassat, J. E., Noto, M. J., Lojek, L. J., Chadha, A. D., Schmitz, J. E., Creech, C. B., & Skaar, E. P. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.09.002 · Cited by 72 · cited 3×
“metabolites promoting respiration underlie the mutualistic interactions [107], although the precise mechanisms of such exchanges remain to be elucidated.”
BackgroundInfluentialGasch, O., Camoez, M., Dominguez, M. A., Padilla, B., Pintado, V., Almirante, B., Lepe, J. A., Lagarde, M., Ruiz de Gopegui, E., Martinez, J. A., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt016 · Cited by 52 · cited 1×
“This study provides a potential connection between inappropriate empiric antibiotic treatment of nosocomial MRSA infections and worsened clinical outcomes [89].”
Background
Research works printed but not linked: 102
- Andersson, 2010, Antibiotic resistance and its cost: is it possible to reverse resistance?, Nat Rev Microbiol, 8, 260, 10.1038/nrmicro2319 · DOI · Paper page
- Luo, 2005, Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure, Proc Natl Acad Sci USA, 102, 541, 10.1073/pnas.0408966102 · DOI
- Roux, 2015, Fitness cost of antibiotic susceptibility during bacterial infection, Sci Transl Med, 7, 297ra114, 10.1126/scitranslmed.aab1621 · DOI
- Skurnik, 2013, Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing, Proc Natl Acad Sci USA, 110, 20747, 10.1073/pnas.1221552110 · DOI
- Ballok, 2013, Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung, J Bacteriol, 195, 4013, 10.1128/JB.00339-13 · DOI
- Boucher, 2009, Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America, Clin Infect Dis, 48, 1, 10.1086/595011 · DOI · Paper page
- Lister, 2009, Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms, Clin Microbiol Rev, 22, 582, 10.1128/CMR.00040-09 · DOI · Paper page
- Li, 2015, The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria, Clin Microbiol Rev, 28, 337, 10.1128/CMR.00117-14 · DOI · Paper page
- Hocquet, 2007, MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin, Antimicrob Agents Chemother, 51, 1582, 10.1128/AAC.01334-06 · DOI
- Salunkhe, 2005, A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance, J Bacteriol, 187, 4908, 10.1128/JB.187.14.4908-4920.2005 · DOI · Paper page
- Xavier, 2010, Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil, BMC Microbiol, 10, 217, 10.1186/1471-2180-10-217 · DOI
- Jalal, 2000, Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients, Antimicrob Agents Chemother, 44, 710, 10.1128/AAC.44.3.710-712.2000 · DOI · Paper page
- Jeannot, 2008, Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump, Antimicrob Agents Chemother, 52, 2455, 10.1128/AAC.01107-07 · DOI · Paper page
- Wolter, 2009, Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype, J Antimicrob Chemother, 64, 294, 10.1093/jac/dkp185 · doi:10.1093/jac/dkp185
- Sanchez, 2002, Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants, J Antimicrob Chemother, 50, 657, 10.1093/jac/dkf185 · DOI · Paper page
- Abdelraouf, 2011, Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa, J Antimicrob Chemother, 66, 1311, 10.1093/jac/dkr105 · DOI
- Hocquet, 2003, Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone, Antimicrob Agents Chemother, 47, 1887, 10.1128/AAC.47.6.1887-1894.2003 · DOI
- Martinez-Ramos, 2014, Overexpression of MexCD-OprJ reduces Pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing, Antimicrob Agents Chemother, 58, 2426, 10.1128/AAC.02012-13 · doi:10.1128/aac.02012-13
- Cosson, 2002, Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system, J Bacteriol, 184, 3027, 10.1128/JB.184.11.3027-3033.2002 · DOI · Paper page
- Olivares, 2012, Overproduction of the multidrug efflux pump MexEF-OprN does not impair Pseudomonas aeruginosa fitness in competition tests, but produces specific changes in bacterial regulatory networks, Environ Microbiol, 14, 1968, 10.1111/j.1462-2920.2012.02727.x · DOI
- Stickland, 2010, Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa, J Proteome Res, 9, 2957, 10.1021/pr9011415 · DOI
- Linares, 2005, Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa, J Bacteriol, 187, 1384, 10.1128/JB.187.4.1384-1391.2005 · DOI · Paper page
- Kohler, 2001, Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa, J Bacteriol, 183, 5213, 10.1128/JB.183.18.5213-5222.2001 · DOI · Paper page
- Lamarche, 2011, MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline), PLoS One, 6, e24310, 10.1371/journal.pone.0024310 · DOI
- Hirakata, 2002, Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa, J Exp Med, 196, 109, 10.1084/jem.20020005 · DOI · Paper page
- Mahajan-Miklos, 1999, Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model, Cell, 96, 47, 10.1016/S0092-8674(00)80958-7 · DOI · Paper page
- Smith, 2006, Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients, Proc Natl Acad Sci USA, 103, 8487, 10.1073/pnas.0602138103 · DOI · Paper page
- Vettoretti, 2009, Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients, Antimicrob Agents Chemother, 53, 1987, 10.1128/AAC.01024-08 · doi:10.1128/aac.01024-08
- Hauser, 2011, Clinical significance of microbial infection and adaptation in cystic fibrosis, Clin Microbiol Rev, 24, 29, 10.1128/CMR.00036-10 · DOI · Paper page
- Trias, 1990, Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides, J Biol Chem, 265, 15680, 10.1016/S0021-9258(18)55452-1 · DOI · Paper page
- Trias, 1990, Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa, Antimicrob Agents Chemother, 34, 52, 10.1128/AAC.34.1.52 · DOI · Paper page
- Yoneyama, 1991, Cloning of the protein D2 gene of Pseudomonas aeruginosa and its functional expression in the imipenem-resistant host, FEBS Lett, 283, 177, 10.1016/0014-5793(91)80582-N · doi:10.1016/0014-5793(91)80582-n
- Riera, 2011, Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem, J Antimicrob Chemother, 66, 2022, 10.1093/jac/dkr232 · DOI · Paper page
- Cabot, 2011, Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study, Antimicrob Agents Chemother, 55, 1906, 10.1128/AAC.01645-10 · doi:10.1128/aac.01645-10
- Pena, 2012, Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections, Antimicrob Agents Chemother, 56, 1265, 10.1128/AAC.05991-11 · DOI
- Wolter, 2008, Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy, Clin Infect Dis, 46, e137, 10.1086/588484 · doi:10.1086/588484
- Bagge, 2002, Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD, Antimicrob Agents Chemother, 46, 3406, 10.1128/AAC.46.11.3406-3411.2002 · DOI
- Tam, 2007, Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa, Clin Microbiol Infect, 13, 413, 10.1111/j.1469-0691.2006.01674.x · DOI
- Moya, 2009, Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein, PLoS Pathog, 5, e1000353, 10.1371/journal.ppat.1000353 · DOI · Paper page
- Moya, 2008, Benefit of having multiple ampD genes for acquiring beta-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa, Antimicrob Agents Chemother, 52, 3694, 10.1128/AAC.00172-08 · doi:10.1128/aac.00172-08
- Folkesson, 2005, Components of the peptidoglycan-recycling pathway modulate invasion and intracellular survival of Salmonella enterica serovar Typhimurium, Cell Microbiol, 7, 147, 10.1111/j.1462-5822.2004.00443.x · DOI
- Balasubramanian, 2012, The regulatory repertoire of Pseudomonas aeruginosa AmpC ss-lactamase regulator AmpR includes virulence genes, PLoS One, 7, e34067, 10.1371/journal.pone.0034067 · DOI
- Oliver, 2000, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection, Science, 288, 1251, 10.1126/science.288.5469.1251 · DOI · Paper page
- Macia, 2005, Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections, Antimicrob Agents Chemother, 49, 3382, 10.1128/AAC.49.8.3382-3386.2005 · DOI · Paper page
- Perron, 2010, Hypermutability and compensatory adaptation in antibiotic-resistant bacteria, Am Nat, 176, 303, 10.1086/655217 · DOI
- Montanari, 2007, Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis, Microbiology, 153, 1445, 10.1099/mic.0.2006/003400-0 · doi:10.1099/mic.0.2006/003400-0
- Alcala-Franco, 2012, Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection, J Antimicrob Chemother, 67, 962, 10.1093/jac/dkr587 · DOI
- Jones, 2015, Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence, Clin Infect Dis, 61, 145, 10.1093/cid/civ225 · DOI
- Bruhn, 2015, Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia, J Infect Dis, 211, 1296
- Doi, 2015, Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options, Semin Respir Crit Care Med, 36, 85, 10.1055/s-0034-1398388 · DOI · Paper page
- Beceiro, 2011, Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system, Antimicrob Agents Chemother, 55, 3370, 10.1128/AAC.00079-11 · DOI · Paper page
- Pelletier, 2013, Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii, Antimicrob Agents Chemother, 57, 4831, 10.1128/AAC.00865-13 · DOI · Paper page
- Snitkin, 2013, Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment, Genome Res, 23, 1155, 10.1101/gr.154328.112 · DOI
- Hraiech, 2013, Impaired virulence and fitness of a colistin-resistant clinical isolate of Acinetobacter baumannii in a rat model of pneumonia, Antimicrob Agents Chemother, 57, 5120, 10.1128/AAC.00700-13 · doi:10.1128/aac.00700-13
- Lopez-Rojas, 2011, Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii, J Infect Dis, 203, 545, 10.1093/infdis/jiq086 · DOI
- Lopez-Rojas, 2013, Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness, Antimicrob Agents Chemother, 57, 4587, 10.1128/AAC.00543-13 · DOI
- Durante-Mangoni, 2015, Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii, Diagn Microbiol Infect Dis, 82, 222, 10.1016/j.diagmicrobio.2015.03.013 · DOI
- Wand, 2015, Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance, J Antimicrob Chemother, 70, 2209, 10.1093/jac/dkv097 · doi:10.1093/jac/dkv097
- Napier, 2013, Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii, MBio, 4, e00021, 10.1128/mBio.00021-13 · DOI
- Beceiro, 2014, Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii, Antimicrob Agents Chemother, 58, 518, 10.1128/AAC.01597-13 · DOI · Paper page
- Moffatt, 2010, Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production, Antimicrob Agents Chemother, 54, 4971, 10.1128/AAC.00834-10 · DOI · Paper page
- Yoon, 2015, Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii, MBio, 6, e00309, 10.1128/mBio.00309-15 · DOI · Paper page
- Rumbo, 2013, Contribution of efflux pumps, porins, and beta-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii, Antimicrob Agents Chemother, 57, 5247, 10.1128/AAC.00730-13 · DOI · Paper page
- Yoon, 2016, Contribution of the Ade resistance-nodulation-cell division-type efflux pumps to fitness and pathogenesis of Acinetobacter baumannii, MBio, 7, e00697, 10.1128/mBio.00697-16 · DOI
- Richmond, 2016, The Acinetobacter baumannii two-component system AdeRS regulates genes required for multidrug efflux, biofilm formation, and virulence in a strain-Specific manner, MBio, 7, e00430
- Gebhardt, 2015, Joint transcriptional control of virulence and resistance to antibiotic and environmental stress in Acinetobacter baumannii, MBio, 6, e01660, 10.1128/mBio.01660-15 · DOI
- Eijkelkamp, 2011, Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions, BMC Genomics, 12, 126, 10.1186/1471-2164-12-126 · DOI · Paper page
- Ezraty, 2013, Fe-S cluster biosynthesis controls uptake of aminoglycosides in a ROS-less death pathway, Science, 340, 1583, 10.1126/science.1238328 · DOI · Paper page
- Kreamer, 2015, The ferrous iron-responsive BqsRS two-component system activates genes that promote cationic stress tolerance, MBio, 6, e02549, 10.1128/mBio.02549-14 · DOI
- Oglesby-Sherrouse, 2014, The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa, Pathog Dis, 70, 307, 10.1111/2049-632X.12132 · DOI
- Tipton, 2015, Phase-variable control of multiple phenotypes in Acinetobacter baumannii strain AB5075, J Bacteriol, 197, 2593, 10.1128/JB.00188-15 · doi:10.1128/jb.00188-15
- Weber, 2015, A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii, Proc Natl Acad Sci USA, 112, 9442, 10.1073/pnas.1502966112 · DOI · Paper page
- Siempos, 2010, Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis, Shock, 33, 590, 10.1097/SHK.0b013e3181cc0418 · DOI
- Andersson, 2014, Microbiological effects of sublethal levels of antibiotics, Nat Rev Microbiol, 12, 465, 10.1038/nrmicro3270 · DOI · Paper page
- Geisinger, 2015, Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii, PLoS Pathog, 11, e1004691, 10.1371/journal.ppat.1004691 · DOI · Paper page
- Hood, 2010, Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations, Antimicrob Agents Chemother, 54, 1029, 10.1128/AAC.00963-09 · doi:10.1128/aac.00963-09
- Novick, 2008, Quorum sensing in staphylococci, Annu Rev Genet, 42, 541, 10.1146/annurev.genet.42.110807.091640 · DOI · Paper page
- Cameron, 2011, The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes, Clin Infect Dis, 53, 576, 10.1093/cid/cir473 · DOI
- Collins, 2010, Offsetting virulence and antibiotic resistance costs by MRSA, ISME J, 4, 577, 10.1038/ismej.2009.151 · DOI
- Lee, 2007, Fitness cost of staphylococcal cassette chromosome mec in methicillin-resistant Staphylococcus aureus by way of continuous culture, Antimicrob Agents Chemother, 51, 1497, 10.1128/AAC.01239-06 · DOI
- Day, 2012, Community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus virulence toward Caenorhabditis elegans compared, Virulence, 3, 576, 10.4161/viru.22120 · DOI
- Diep, 2008, The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus, J Infect Dis, 197, 1523, 10.1086/587907 · DOI · Paper page
- Rudkin, 2012, Methicillin resistance reduces the virulence of healthcare-associated methicillin-resistant Staphylococcus aureus by interfering with the agr quorum sensing system, J Infect Dis, 205, 798, 10.1093/infdis/jir845 · DOI · Paper page
- Kaito, 2011, Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence, PLoS Pathog, 7, e1001267, 10.1371/journal.ppat.1001267 · DOI
- Queck, 2009, Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA, PLoS Pathog, 5, e1000533, 10.1371/journal.ppat.1000533 · DOI · Paper page
- Muller, 2015, Poorly cross-Linked peptidoglycan in MRSA due to mecA induction activates the inflammasome and exacerbates immunopathology, Cell Host Microbe, 18, 604, 10.1016/j.chom.2015.10.011 · DOI
- Peleg, 2009, Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection, J Infect Dis, 199, 532, 10.1086/596511 · DOI · Paper page
- Majcherczyk, 2008, Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis, Microb Pathog, 45, 408, 10.1016/j.micpath.2008.09.003 · DOI
- Burnie, 2000, Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin, Clin Infect Dis, 31, 684, 10.1086/314035 · DOI
- Howden, 2008, Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia, BMC Microbiol, 8, 39, 10.1186/1471-2180-8-39 · DOI
- Cameron, 2012, Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus, J Infect Dis, 205, 1677, 10.1093/infdis/jis252 · DOI
- Renzoni, 2011, Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureus, PLoS One, 6, e21577, 10.1371/journal.pone.0021577 · DOI
- Burnside, 2010, Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase, PLoS One, 5, e11071, 10.1371/journal.pone.0011071 · DOI · Paper page
- Sun, 2012, Protein cysteine phosphorylation of SarA/MgrA family transcriptional regulators mediates bacterial virulence and antibiotic resistance, Proc Natl Acad Sci USA, 109, 15461, 10.1073/pnas.1205952109 · DOI · Paper page
- Cheung, 2008, The SarA protein family of Staphylococcus aureus, Int J Biochem Cell Biol, 40, 355, 10.1016/j.biocel.2007.10.032 · DOI · Paper page
- Gao, 2013, The RpoB H481Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus, J Infect Dis, 207, 929, 10.1093/infdis/jis772 · DOI
- Besier, 2007, Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease, J Clin Microbiol, 45, 168, 10.1128/JCM.01510-06 · DOI · Paper page
- Musher, 1977, Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals, J Infect Dis, 136, 360, 10.1093/infdis/136.3.360 · DOI
- Sendi, 2009, Staphylococcus aureus as an intracellular pathogen: the role of small colony variants, Trends Microbiol, 17, 54, 10.1016/j.tim.2008.11.004 · DOI · Paper page
- Cheng, 2011, A play in four acts: Staphylococcus aureus abscess formation, Trends Microbiol, 19, 225, 10.1016/j.tim.2011.01.007 · DOI · Paper page
- Hoffman, 2006, Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa, Proc Natl Acad Sci USA, 103, 19890, 10.1073/pnas.0606756104 · DOI · Paper page
- Ensminger, 2013, Experimental evolution of pathogenesis: “patient” research, PLoS Pathog, 9, e1003340, 10.1371/journal.ppat.1003340 · DOI
Cited by
Makvandi, P., Wang, C., Zare, E. N., Borzacchiello, A., Niu, L., & Tay, F. R. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910021 · Cited by 737
Evolutionary Pathways and Trajectories in Antibiotic Resistance
Baquero, F., Martínez, J. L., F. Lanza, V., Rodríguez-Beltrán, J., Galán, J. C., San Millán, A., Cantón, R., & Coque, T. M. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00050-19 · Cited by 295
The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases
ur Rahman, S., Ali, T., Ali, I., Khan, N. A., Han, B., & Gao, J. (2018) · BioMed Research International · doi:10.1155/2018/9519718 · Cited by 283
Metadata
- Authors
- Geisinger, E., & Isberg, R. R.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-15
- Volume
- 215
- Issue
- suppl_1
- Pages
- S9-S17
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2598043550
- Cited by
- 197
- References
- 6
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- National Institute of Allergy and Infectious Diseases
- Howard Hughes Medical Institute (F32-AI098358, U01-AI124302)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria. https://app.cochat.ai/papers/10.1093/infdis/jiw402
- The paper
- Geisinger, E., & Isberg, R. R. (2017). Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiw402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.